Current health expenditure (CHE) per capita (US$) vs Measles-containing-vaccine second-dose (MCV2) immunization coverage (%) in Andorra

In 2023, current health expenditure (CHE) per capita (US$) in Andorra was 3,605.2 USD; measles-containing-vaccine second-dose (MCV2) immunization coverage (%) was 96%.

Change the pair

Compare different indicators

The series

Over time

Andorra, annual figures, spaced by time from 2000 to 2023 . Different units, drawn on separate scales and clipped to the years both series publish; earlier history stays on each indicator’s own page. Read the values, not the heights.

Current health expenditure (CHE) per capita (US$)

Unit: USD · 24 observations

Line chart
Current health expenditure (CHE) per capita (US$)Current health expenditure (CHE) per capita (US$). 24 observations from 2000 to 2023, ranging from 1,294.1 USD to 3,668.4 USD. Latest value 3,605.2 USD (2023). USD 0 1,000 2,000 3,000 4,000 2000 2004 2008 2012 2016 2020 3,605
Current health expenditure (CHE) per capita (US$)Current health expenditure (CHE) per capita (US$). 24 observations from 2000 to 2023, ranging from 1,294.1 USD to 3,668.4 USD. Latest value 3,605.2 USD (2023). USD 0 1,000 2,000 3,000 4,000 2000 2004 2008 2012 2016 2020 3,605
Current health expenditure (CHE) per capita (US$)Current health expenditure (CHE) per capita (US$). 24 observations from 2000 to 2023, ranging from 1,294.1 USD to 3,668.4 USD. Latest value 3,605.2 USD (2023). USD 0 1,000 2,000 3,000 4,000 2000 2004 2008 2012 2016 2020 3,605
View the underlying data
Current health expenditure (CHE) per capita (US$)
Period Type Value
2000 Actual 1,294.1 USD
2001 Actual 1,378.7 USD
2002 Actual 1,590.7 USD
2003 Actual 1,888.1 USD
2004 Actual 2,060.3 USD
2005 Actual 2,279.5 USD
2006 Actual 2,152 USD
2007 Actual 2,388.2 USD
2008 Actual 2,790.1 USD
2009 Actual 2,679.7 USD
2010 Actual 3,286.5 USD
2011 Actual 3,555.5 USD
2012 Actual 2,788.7 USD
2013 Actual 2,887 USD
2014 Actual 3,005.2 USD
2015 Actual 2,672.5 USD
2016 Actual 2,785.6 USD
2017 Actual 2,876.2 USD
2018 Actual 3,159.2 USD
2019 Actual 3,021.1 USD
2020 Actual 3,282 USD
2021 Actual 3,668.4 USD
2022 Actual 3,190.1 USD
2023 Actual 3,605.2 USD
Source: WHO · CC BY 4.0 · Full series

Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)

Unit: % · 24 observations

Line chart

Estimates are listed as such in the table below

Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)Measles-containing-vaccine second-dose (MCV2) immunization coverage (%). 24 observations from 2000 to 2023, ranging from 0% to 97%. Latest value 96% (2023). % 0 20 40 60 80 100 2000 2004 2008 2012 2016 2020 96%
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)Measles-containing-vaccine second-dose (MCV2) immunization coverage (%). 24 observations from 2000 to 2023, ranging from 0% to 97%. Latest value 96% (2023). % 0 30 60 90 120 2000 2004 2008 2012 2016 2020 96%
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)Measles-containing-vaccine second-dose (MCV2) immunization coverage (%). 24 observations from 2000 to 2023, ranging from 0% to 97%. Latest value 96% (2023). % 0 30 60 90 120 2000 2004 2008 2012 2016 2020 96%
View the underlying data
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)
Period Type Value
2000 Estimate 0%
2001 Estimate 0%
2002 Estimate 0%
2003 Estimate 0%
2004 Estimate 0%
2005 Estimate 0%
2006 Estimate 0%
2007 Estimate 80%
2008 Estimate 86%
2009 Estimate 82%
2010 Estimate 86%
2011 Estimate 82%
2012 Estimate 89%
2013 Estimate 91%
2014 Estimate 90%
2015 Estimate 88%
2016 Estimate 90%
2017 Estimate 94%
2018 Estimate 95%
2019 Estimate 97%
2020 Estimate 93%
2021 Estimate 97%
2022 Estimate 96%
2023 Estimate 96%
Source: WHO · CC BY 4.0 · Full series

Shared periods

Side by side

24 periods are published for both series in Andorra as annual figures on the same basis. Comparing anything else would mean comparing different periods.

Period Current health expenditure (CHE) per capita (US$) Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)
2000 1,294.1 USD WHO 0% WHO
2001 1,378.7 USD WHO 0% WHO
2002 1,590.7 USD WHO 0% WHO
2003 1,888.1 USD WHO 0% WHO
2004 2,060.3 USD WHO 0% WHO
2005 2,279.5 USD WHO 0% WHO
2006 2,152 USD WHO 0% WHO
2007 2,388.2 USD WHO 80% WHO
2008 2,790.1 USD WHO 86% WHO
2009 2,679.7 USD WHO 82% WHO
2010 3,286.5 USD WHO 86% WHO
2011 3,555.5 USD WHO 82% WHO
2012 2,788.7 USD WHO 89% WHO
2013 2,887 USD WHO 91% WHO
2014 3,005.2 USD WHO 90% WHO
2015 2,672.5 USD WHO 88% WHO
2016 2,785.6 USD WHO 90% WHO
2017 2,876.2 USD WHO 94% WHO
2018 3,159.2 USD WHO 95% WHO
2019 3,021.1 USD WHO 97% WHO
2020 3,282 USD WHO 93% WHO
2021 3,668.4 USD WHO 97% WHO
2022 3,190.1 USD WHO 96% WHO
2023 3,605.2 USD WHO 96% WHO

Provenance

Where these numbers come from

Current health expenditure (CHE) per capita (US$)

Per capita current health expenditure expressed in US dollars, as published by the WHO Global Health Expenditure Database.

24 observations charted in Andorra · source organisations: WHO

Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)

The percentage of children who have received two doses of measles-containing vaccine (MCV2) in a given year, according to the nationally recommended schedule, based on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).

24 observations charted in Andorra (of 26 annual records) · source organisations: WHO

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related